UBC researchers have engineered a gut-friendly bacterium, Bacteroides thetaiotaomicron, to act as a living biosensor that glows brightly under normal conditions and dims when it detects gut disruptions such as osmotic stress—a common feature of conditions like celiac disease and inflammatory bowel disease. Unlike current invasive diagnostic tools that offer only momentary snapshots, this engineered bacterium can provide continuous, non-invasive monitoring through stool samples. Tested in mice, the sensor detected even subtle, symptom-free changes and remained stable for weeks, suggesting potential for early disease detection and long-term gut‑health tracking. The team envisions future versions that detect multiple signals—such as oxygen, temperature, and pH—or even deliver targeted treatments when illness‑related changes arise.

About The Study: In this nationwide cohort study of patients with diabetes and prior major adverse limb events, treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with significantly lower risks of recurrent limb events, cardiovascular events, all-cause mortality, and kidney disease progression compared with dipeptidyl peptidase-4 inhibitors. These findings support the preferential use of GLP-1 RAs for secondary prevention in this high-risk population.

About The Study: In this cohort study, exposure to adverse experiences throughout life was associated with increased risks of dementia and stroke, with depression mediating these associations. These findings highlight the importance of implementing life-course interventions that address both psychological trauma and mental health to reduce the burden of neurovascular diseases.

New research uncovers how medically complex conditions that begin in childhood affect care in adult hospitals. 

UCLA Health researchers have created a comprehensive map showing how eight different genetic mutations associated with autism spectrum disorder affect early brain development, providing new insights into the ways diverse genetic causes may lead to shared features and symptoms of the disorder.

(WASHINGTON — Jan. 28, 2026) — The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the Society’s peer-reviewed journal Blood Advances, were developed following a rigorous review process and aim to improve and accelerate diagnosis for individuals living with the disorder.  

More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and reduce risks for T2D and its complications. Recently published findings from a randomized controlled trial (RCT) demonstrate that eating 6-7 ounces of beef per day does not impact risk factors for T2D, as well as other cardiometabolic health markers, in adults with prediabetes. The study, “Effects of Diets Containing Beef Compared with Poultry on Pancreatic β -Cell Function and Other Cardiometabolic Health Indicators in Males and Females with Prediabetes: A Randomized, Crossover Trial,” was published in Current Developments in Nutrition.